<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01808911</url>
  </required_header>
  <id_info>
    <org_study_id>2011/090/HP</org_study_id>
    <nct_id>NCT01808911</nct_id>
  </id_info>
  <brief_title>Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)</brief_title>
  <acronym>CREHA</acronym>
  <official_title>Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CREHA project is a study comparing steroid combined with cyclophosphamide versus steroid
      combined with rituximab in patients with acquired haemophilia. The study will test the
      hypothesis that steroid combined with cyclophosphamide is more effective than steroid plus
      rituximab for FVIII inhibitor eradication in acquired haemophilia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CREHA project is a multicenter, randomized, controlled efficacity and safety study comparing
      steroid combined with cyclophosphamide versus steroid combined with rituximab in patients
      with acquired haemophilia. The study will test the hypothesis that steroid combined with
      cyclophosphamide is more effective than steroid plus rituximab for FVIII inhibitor
      eradication in acquired haemophilia
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2012</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary objective</measure>
    <time_frame>During 18 months</time_frame>
    <description>Demonstrate the inferiority of steroid combined with rituximab as compared to the recommended immunosuppressive approach (steroid combined with cysclophosphamide for 21 to 42 days) as the first-line immunosuppressive therapy for FVIII inhibitor eradication in acquired haemophilia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary efficacy outcome</measure>
    <time_frame>During 18 months</time_frame>
    <description>The primary efficacy outcome is the proportion of patients achieving complete remission defined as titer FVII inhibitor lower than 0.4 Bethesda unit and factor VIII level &gt; 50%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary safety outcomes</measure>
    <time_frame>During 18 months</time_frame>
    <description>The primary safety outcomes will be the occurrence of major bleeding and infection related immunosuppressive treatment adverse events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary objective</measure>
    <time_frame>6 months, 12 months and 18 months</time_frame>
    <description>Secondary objective are time to complete remission, number of relapse at M6, M12, M18, adverse events (especially related to bleeding or to immunosuppressive treatment) and mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other key safety outcome</measure>
    <time_frame>During 18 months</time_frame>
    <description>The other key safety outcome are clinically relevant non major bleeding, diabetes and mortality non-related with acquired haemophilia or immunosuppressive therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Acquired Haemophilia</condition>
  <arm_group>
    <arm_group_label>Bras A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Steroid 1mg/kg/d and Cyclophosphamide 2mg/kg/d</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bras B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Steroid 1mg/kg/d and Rituximab 375 mg/m2 every week during four weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid + cyclophosphamide</intervention_name>
    <arm_group_label>Bras A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Steroid + rituximab</intervention_name>
    <arm_group_label>Bras B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men or women

          -  women post-menpausal or with ongoing contraception

          -  18 years old or more

          -  diagnosis of acquired hemophilia

          -  patient must be insured

          -  patient has provided written informed consent prior to enrolment

          -  patient compliant

        Exclusion Criteria:

          -  constitutional hemophilia

          -  chemotherapy

          -  ongoing treatment with prednisone &gt; 20mg further more 1 month

          -  ongoing treatment with prednisone &gt;0.7 mg/d further more 10 days

          -  thrombocytopenia

          -  leukopenia

          -  chronic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hervé LEVESQUE, MD, PhD</last_name>
    <phone>(0)2 32 88 90 01</phone>
    <phone_ext>+33</phone_ext>
    <email>herve.levesque@chu-rouen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean SCHMIDT, MD</last_name>
      <phone>(0)3 22 66 82 30</phone>
      <phone_ext>+33</phone_ext>
      <email>schmidt.jean@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Jean SCHMIDT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier FAIN, MD, PhD</last_name>
      <phone>(0)1 48 02 63 96</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.fain@jvr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier FAIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves LAURIAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Ambroise Paré</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92104</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas HANSLIK, MD, PhD</last_name>
      <phone>(0)1 49 09 56 38</phone>
      <phone_ext>+33</phone_ext>
      <email>thomas.hanslik@apr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas HANSLIK, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Brest - Hospital La cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélien DELLUC, MD</last_name>
      <phone>(0)2 98 34 73 36</phone>
      <phone_ext>+33</phone_ext>
      <email>aurelien.delluc@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Aurélien DELLUC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brigitte PAN-PETESCH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Béziers</name>
      <address>
        <city>Béziers</city>
        <zip>34525</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric OZIOL, MD</last_name>
      <phone>(0)4 67 35 70 56</phone>
      <phone_ext>+33</phone_ext>
      <email>eric.oziol@ch-beziers.fr</email>
    </contact>
    <investigator>
      <last_name>Eric OZIOL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris BIENVENU, MD, PhD</last_name>
      <phone>(0)2 31 06 45 84</phone>
      <phone_ext>+33</phone_ext>
      <email>bienvenu-b@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Boris BIENVENU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital G. Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc ANDRE, MD,PhD</last_name>
      <phone>(0)4 73 75 14 35</phone>
      <phone_ext>+33</phone_ext>
      <email>mandre@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Marc ANDRE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc MICHEL, MD, PhD</last_name>
      <phone>(0)1 49 81 20 76</phone>
      <phone_ext>+33</phone_ext>
      <email>marc.michel@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Marc MICHEL, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Dijon - Hospital Général</name>
      <address>
        <city>Dijon</city>
        <zip>21033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François BESANCENOT, MD, PhD</last_name>
      <phone>(0)3 80 29 37 73</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-francois.besancenot@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-François BESANCENOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard BONNOTTE, MD, PhD</last_name>
      <phone>(0)3 80 29 34 32</phone>
      <phone_ext>+33</phone_ext>
      <email>bernard.bonnotte@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard BONNOTTE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence BOUILLET, MD</last_name>
      <phone>(0)4 76 7655 20</phone>
      <phone_ext>+33</phone_ext>
      <email>Lbouillet@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence BOUILLET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Kremlin-Bicêtre</name>
      <address>
        <city>Le Kremlin-bicetre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier LAMBOTTE, MD, PhD</last_name>
      <phone>(0)1 45 21 27 83</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.lambotte@bct.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier LAMBOTTE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Regional Hospital of Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc LAMBERT, MD</last_name>
      <phone>(0)3 20 44 42 96</phone>
      <phone_ext>+33</phone_ext>
      <email>marc.lambert@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Marc LAMBERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jenny GOUDEMAND, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>university Hospital of Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth VIDAL-CATHALA, MD,PhD</last_name>
      <phone>(0)5 55 05 66 41</phone>
      <phone_ext>+33</phone_ext>
      <email>elisabeth.vidal@unilim.fr</email>
    </contact>
    <investigator>
      <last_name>Elizabeth VIDAL-CATHALA, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HM, University Hospital La Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas SCHLEINITZ, MD, PhD</last_name>
      <phone>(0)4 91 38 35 01</phone>
      <phone_ext>+33</phone_ext>
      <email>nicolas.schleinitz@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas SCHLEINITZ, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Saint-Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain LE QUELLEC, MD, PhD</last_name>
      <phone>(0)4 67 33 70 17</phone>
      <phone_ext>+33</phone_ext>
      <email>a-lequellec@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Alain LE QUELLEC, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Center of Haemophilia Treatment (CRTH) de Lorraine</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brigit FROTSCHER, MD</last_name>
      <phone>(0) 03 83 15 37 84</phone>
      <phone_ext>+33</phone_ext>
      <email>b.frotscher@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Brigit FROTSCHER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Nantes, Hospital Hôtel-Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed HAMIDOU, MD, PhD</last_name>
      <phone>(0)2 40 08 31 46</phone>
      <phone_ext>+33</phone_ext>
      <email>mohamed.hamidou@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Mohamed HAMIDOU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc TROSSAËRT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Archet 1</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Yves JEANDEL, MD</last_name>
      <phone>(0)4 92 03 58 23</phone>
      <phone_ext>+33</phone_ext>
      <email>jeandel.p@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre-Yves JEANDEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Saint-Louis</name>
      <address>
        <city>Paris 10e</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dominique FARGE-BANCEL, MD, PhD</last_name>
      <phone>(0)1 42 49 97 67</phone>
      <phone_ext>+33</phone_ext>
      <email>dominique.farge-bancel@sls.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique FARGE-BANCEL, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Pitié-Salpêtrière</name>
      <address>
        <city>Paris 13e</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zahir AMOURA, MD, PhD</last_name>
      <phone>(0)1 42 17 80 01</phone>
      <phone_ext>+33</phone_ext>
      <email>zahir.amoura@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Zahir AMOURA, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Cochin</name>
      <address>
        <city>Paris 14e</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe BLANCHE, MD</last_name>
      <phone>(0)1 58 41 21 26</phone>
      <phone_ext>+33</phone_ext>
      <email>philippe.blanche@cch.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe BLANCHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Bichat</name>
      <address>
        <city>Paris 18e</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas PAPO, MD, PhD</last_name>
      <phone>(0)1 40 25 87 05</phone>
      <phone_ext>+33</phone_ext>
      <email>thomas.papo@bch.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas PAPO, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Europen Hospital of Georges Pompidou (HEGP)</name>
      <address>
        <city>Paris</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques POUCHOT, MD, PhD</last_name>
      <phone>(0)1 56 09 33 32</phone>
      <phone_ext>+33</phone_ext>
      <email>jacques.pouchot@egp.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jacques POUCHOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bordeaux - Hospital Haut-Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François VIALLARD, MD, PhD</last_name>
      <phone>(0)5 57 65 64 83</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-francois.viallard@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-François VIALLARD, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Lyon Sud</name>
      <address>
        <city>Pierre-Benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle DURIEU, MD, PhD</last_name>
      <phone>(0)4 78 86 14 65</phone>
      <phone_ext>+33</phone_ext>
      <email>Isabelle.durieu@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle DURIEU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal ROBLOT, MD, PhD</last_name>
      <phone>(0) 5 49 44 44 22</phone>
      <phone_ext>+33</phone_ext>
      <email>p.roblot@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal ROBLOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sud / Hospital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick JEGO, MD, PhD</last_name>
      <phone>(0)2 99 26 71 28</phone>
      <phone_ext>+33</phone_ext>
      <email>patrick.jego@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick JEGO, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoît GUILLET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé LEVESQUE, MD, PhD</last_name>
      <phone>(0) 2 32 88 90 01</phone>
      <phone_ext>+33</phone_ext>
      <email>herve.levesque@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Ygal BENHAMOU, MD</last_name>
      <phone>(0)2 32 88 90 14</phone>
      <phone_ext>+33</phone_ext>
      <email>ygal.benhamou@chu-rouen.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Hervé LEVESQUE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ygal BENHAMOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Loïc BEGARIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyrielle ASSIE-CHAUVIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas GIRSZYN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alice PROUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Severine JOSSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle MARIE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanne-Yvonne BORG, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique LE CAM-DUCHEZ, Md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Nord</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal CATHEBRAS, MD, PhD</last_name>
      <phone>(0)4 77 82 83 42</phone>
      <phone_ext>+33</phone_ext>
      <email>pascal.cathebras@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal CATHEBRAS, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Regional Hospital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne BOUGARIT, MD, PhD</last_name>
      <phone>(0)3 88 12 75 94</phone>
      <phone_ext>+33</phone_ext>
      <email>anne.bourgarit-durand@chur-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Anne BOURGARIT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard GOICHOT, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lélia GRUNEBAUM-HIMY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique DESPREZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent SAILLER, MD, PhD</last_name>
      <phone>(0)5 61 77 96 78</phone>
      <phone_ext>+33</phone_ext>
      <email>sailler.l@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent SAILLER, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-France THIERCELIN-LEGRAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel ADOUE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique CHAUVEAU, MD, PhD</last_name>
      <phone>(0)5 61 32 32 79</phone>
      <phone_ext>+33</phone_ext>
      <email>chauveau.d@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique CHAUVEAU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre SIE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sophie VOISIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopsital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François MAILLOT, MD, PhD</last_name>
      <phone>(0)2 47 47 47 27</phone>
      <phone_ext>+33</phone_ext>
      <email>maillot@med.univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Francois MAILLOT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves GRUEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2013</study_first_posted>
  <last_update_submitted>May 25, 2018</last_update_submitted>
  <last_update_submitted_qc>May 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acquired haemophilia</keyword>
  <keyword>Comparative and randomized study</keyword>
  <keyword>Cyclophosphamide</keyword>
  <keyword>Rituximab</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Rituximab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

